Tunisian Lung Cancer Study
ConditionPulmonary Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDacima Consulting
About this trial
This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age more than 18 years
Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
Informed consent
Disqualifiers
None
Trial population
All participants diagnosed with histologically confirmed lung cancer will be included in the study, regardless of sex, age, stage and histological subtype. Patients will be enrolled in the study consecutively The study will be conducted in different regions of Tunisia, encompassing several sites covering different departments in public hospitals.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Diagnostic delay
Delay to set the pulmonary cancer diagnosis
Time frame
Day 12
Survival
Overall survival
Time frame
12 months3
Relapse
Time to relapse
Time frame
12 monthsSecondary outcomes
1
Recommendation Compliance
Compliance to national and international guidance of pulmonary cancer management
Time frame
Day 1Other outcomes
1
Multidisciplinary Consultation Meetings
Number of Multidisciplinary Consultation Meetings
Time frame
12 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Dacima Consulting
Lead sponsor
The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM)
Collaborator
Tunisian Society of Respiratory Diseases and Allergology
Collaborator
Tunisian Society of Medical Oncology
Collaborator
Source ClinicalTrials.gov